• 1
    Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry. 2001; 58: 573578.
  • 2
    Mortensen PB, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand. 1990; 81: 372377.
  • 3
    Oksbjerg Dalton S, Munk Laursen T, Mellemkjaer L, Johansen C, Mortensen PB. Schizophrenia and the risk for breast cancer. Schizophr Res. 2003; 62: 8992.
  • 4
    Dupont A, Jensen OM, Stromgren E, Jablensky A. Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In: ten Horn GHMM, Giel R, Gulbinat WH, Henderson JH, editors. Psychiatric case registers in public health. Amsterdam: Elsevier, 1986: 229239.
  • 5
    Mortensen PB. The occurrence of cancer in first admitted schizophrenic patients. Schizophr Res. 1994; 12: 185194.
  • 6
    Saku M, Tokudome S, Ikeda M, et al. Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol. 1995; 24: 366372.
  • 7
    Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000; 177: 212217.
  • 8
    Cohen M, Dembling B, Schorling J. The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res. 2002; 57: 139146.
  • 9
    Gulbinat W, Dupont A, Jablensky A, et al. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiatry. 1992; (18 Suppl): 7583.
  • 10
    de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995; 152: 453455.
  • 11
    Zammit S, Allebeck P, Dalman C, Lundberg I, Hemmingsson T, Lewis G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry. 2003; 160: 22162221.
  • 12
    Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003; 41: 560570.
  • 13
    Druss BG, Rosenheck RA. Use of medical services by veterans with mental disorders. Psychosomatics. 1997; 38: 451458.
  • 14
    Tsuang MT, Woolson RF, Fleming JA. Premature deaths in schizophrenia and affective disorders. Arch Gen Psychiatry. 1980; 37: 979983.
  • 15
    Barak Y, Mirecki I, Knobler HY, Natan Z, Aizenberg D. Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Psychopharmacology (Berl). 2004; 175: 215219. Epub 2004 Feb 4.
  • 16
    Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer. 2003; 13: 2327.
  • 17
    Central Bureau of Statistics of Israel. Census of Population and Housing. Pub. No. 1, Population and Households [Table 2.23]. Tel-Aviv, Israel: Central Bureau of Statistics, Israel, 2002: 274.
  • 18
    Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull. 1996; 22: 413430.
  • 19
    Catts VS, Catts SV. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res. 2000; 41: 405415.
  • 20
    Dupont A. A national psychiatric case register as a tool for mental health planning, research and administration. The Danish model. In: Laska M, Gulbinat WH, Regier DA, editors. Information support to mental health programs: an international perspective. New York: Human Sciences Press, 1983: 257274.
  • 21
    Shalev AY, Abaramowitz MZ, Kaplan De-Nour A. Structured clinical interview for axis I DSM-IV patient edition. Jerusalem: Hadassah University Hospital, 1994.
  • 22
    Halbreich U, Shen J, Panaro V. Are chronic psychiatric patients at increased risk for developing breast cancer? Am J Psychiatry. 1996; 153: 559560.
  • 23
    Halbreich U, Kinon BJ, Gilmore JA, Kahn LS. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology. 2003; 28: 5367.
  • 24
    Dalton SO, Munk Laursen T, Mellemkjaer L, Johansen C, Mortensen PB. Schizophrenia and the risk for breast cancer. Schizophr Res. 2003; 62: 8992.
  • 25
    Fox BH, Howell MA. Cancer risk among psychiatric patients: a hypothesis. Int J Epidemiol. 1974; 3: 207208.
  • 26
    Park JK, Lee HJ, Kim JW, et al. Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients. Schizophr Res. 2004; 67: 7174.
  • 27
    Yang Y, Xiao Z, Chen W, et al. Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population. Neurosci Lett. 2004; 369: 126131.
  • 28
    Dalton SO, Laursen TM, Mellemkjaer L, Johansen C, Mortensen PB. Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry 2004; 161: 903908.